Genetic Technologies Announces Proposed Joint Venture with Beijing Zishan Health Consultancy Limited
August 16, 2018 05:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Secures A$20 Million Equity Placement Facility
August 08, 2018 05:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Formalises Strategic Alliance with Blockchain Global
August 02, 2018 06:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Announces Appointment of Swisstec as Non-Exclusive Asian Distributor
July 30, 2018 06:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 30, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Limited Announces Expansion of Genetic Risk Assessment Tests and October Launch of New Breast Cancer and Colorectal Cancer Tests
July 16, 2018 05:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Announces Heads of Agreement with Swisstec
June 19, 2018 05:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, June 19, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Announces Binding Project Shivom Agreement
June 07, 2018 05:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, June 07, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE), “Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility
May 01, 2018 05:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, May 01, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies...
Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test
March 16, 2018 05:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain...
Genetic Technologies Limited: Project Shivom Strategic Alliance
March 06, 2018 05:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...